JPWO2020249979A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020249979A5 JPWO2020249979A5 JP2021571935A JP2021571935A JPWO2020249979A5 JP WO2020249979 A5 JPWO2020249979 A5 JP WO2020249979A5 JP 2021571935 A JP2021571935 A JP 2021571935A JP 2021571935 A JP2021571935 A JP 2021571935A JP WO2020249979 A5 JPWO2020249979 A5 JP WO2020249979A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- administered
- aenh
- acute
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962861758P | 2019-06-14 | 2019-06-14 | |
| US62/861,758 | 2019-06-14 | ||
| GBGB1910125.2A GB201910125D0 (en) | 2019-07-15 | 2019-07-15 | Treatments of angioedema |
| GB1910125.2 | 2019-07-15 | ||
| PCT/GB2020/051441 WO2020249979A1 (en) | 2019-06-14 | 2020-06-15 | Treatments of angioedema |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022537913A JP2022537913A (ja) | 2022-08-31 |
| JPWO2020249979A5 true JPWO2020249979A5 (zh) | 2023-07-27 |
Family
ID=67700187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571935A Pending JP2022537913A (ja) | 2019-06-14 | 2020-06-15 | 血管性浮腫の治療 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20220226293A1 (zh) |
| EP (1) | EP3982961A1 (zh) |
| JP (1) | JP2022537913A (zh) |
| KR (1) | KR20220024221A (zh) |
| CN (2) | CN113993520A (zh) |
| AR (1) | AR119159A1 (zh) |
| AU (1) | AU2020293616A1 (zh) |
| BR (1) | BR112021024447A2 (zh) |
| CA (1) | CA3142220A1 (zh) |
| CL (2) | CL2021003243A1 (zh) |
| GB (1) | GB201910125D0 (zh) |
| IL (1) | IL288612A (zh) |
| MA (1) | MA56188A (zh) |
| MX (1) | MX2021014558A (zh) |
| SG (1) | SG11202113375PA (zh) |
| TW (1) | TW202112371A (zh) |
| WO (1) | WO2020249979A1 (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201609607D0 (en) | 2016-06-01 | 2016-07-13 | Kalvista Pharmaceuticals Ltd | Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts |
| GB201719881D0 (en) | 2017-11-29 | 2018-01-10 | Kalvista Pharmaceuticals Ltd | Solid forms of plasma kallikrein inhibitor and salts thereof |
| EP4010333A1 (en) | 2019-08-09 | 2022-06-15 | Kalvista Pharmaceuticals Limited | Plasma kallikrein inhibitors |
| EP4288036A1 (en) | 2022-04-27 | 2023-12-13 | Kalvista Pharmaceuticals Limited | Formulations of a plasma kallikrein inhibitor |
| CN116003386B (zh) * | 2022-11-20 | 2024-03-26 | 药康众拓(北京)医药科技有限公司 | 一种氘代n-苄基吡啶酮吡唑甲酰胺类化合物、药物组合物和用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5187157A (en) | 1987-06-05 | 1993-02-16 | Du Pont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
| GB9019558D0 (en) | 1990-09-07 | 1990-10-24 | Szelke Michael | Enzyme inhibitors |
| SE9301911D0 (sv) | 1993-06-03 | 1993-06-03 | Ab Astra | New peptide derivatives |
| US5589467A (en) | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
| GB0205527D0 (en) | 2002-03-08 | 2002-04-24 | Ferring Bv | Inhibitors |
| US7429604B2 (en) | 2004-06-15 | 2008-09-30 | Bristol Myers Squibb Company | Six-membered heterocycles useful as serine protease inhibitors |
| AU2007281220B2 (en) | 2006-07-31 | 2013-08-15 | Activesite Pharmaceuticals, Inc. | Inhibitors of plasma kallikrein |
| DE102006050672A1 (de) | 2006-10-24 | 2008-04-30 | Curacyte Discovery Gmbh | Hemmstoffe des Plasmins und des Plasmakallikreins |
| JP2013121919A (ja) | 2010-03-25 | 2013-06-20 | Astellas Pharma Inc | 血漿カリクレイン阻害剤 |
| US8921319B2 (en) | 2010-07-07 | 2014-12-30 | The Medicines Company (Leipzig) Gmbh | Serine protease inhibitors |
| EP2595986A2 (en) | 2010-07-14 | 2013-05-29 | Addex Pharma SA | Novel 2-amino-4-pyrazolyl-thiazole derivatives and their use as allosteric modulators of metabotropic glutamate receptors |
| US9290485B2 (en) | 2010-08-04 | 2016-03-22 | Novartis Ag | N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides |
| GB2494851A (en) | 2011-07-07 | 2013-03-27 | Kalvista Pharmaceuticals Ltd | Plasma kallikrein inhibitors |
| GB201300304D0 (en) | 2013-01-08 | 2013-02-20 | Kalvista Pharmaceuticals Ltd | Benzylamine derivatives |
| ES2626968T3 (es) | 2013-05-23 | 2017-07-26 | Kalvista Pharmaceuticals Limited | Derivados heterocíclicos |
| GB201421083D0 (en) | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | Enzyme inhibitors |
| GB201721515D0 (en) * | 2017-12-21 | 2018-02-07 | Kalvista Pharmaceuticals Ltd | Dosage forms comprising a plasma kallikrein inhibtor |
-
2019
- 2019-07-15 GB GBGB1910125.2A patent/GB201910125D0/en not_active Ceased
-
2020
- 2020-06-15 BR BR112021024447A patent/BR112021024447A2/pt unknown
- 2020-06-15 US US17/617,456 patent/US20220226293A1/en active Pending
- 2020-06-15 CA CA3142220A patent/CA3142220A1/en active Pending
- 2020-06-15 AU AU2020293616A patent/AU2020293616A1/en active Pending
- 2020-06-15 TW TW109120109A patent/TW202112371A/zh unknown
- 2020-06-15 CN CN202080043658.4A patent/CN113993520A/zh active Pending
- 2020-06-15 JP JP2021571935A patent/JP2022537913A/ja active Pending
- 2020-06-15 MA MA056188A patent/MA56188A/fr unknown
- 2020-06-15 WO PCT/GB2020/051441 patent/WO2020249979A1/en active Application Filing
- 2020-06-15 MX MX2021014558A patent/MX2021014558A/es unknown
- 2020-06-15 CN CN202410143627.6A patent/CN118078821A/zh active Pending
- 2020-06-15 SG SG11202113375PA patent/SG11202113375PA/en unknown
- 2020-06-15 KR KR1020217043375A patent/KR20220024221A/ko unknown
- 2020-06-15 EP EP20734285.8A patent/EP3982961A1/en active Pending
- 2020-06-16 AR ARP200101682A patent/AR119159A1/es unknown
-
2021
- 2021-12-02 IL IL288612A patent/IL288612A/en unknown
- 2021-12-06 CL CL2021003243A patent/CL2021003243A1/es unknown
-
2023
- 2023-03-10 CL CL2023000699A patent/CL2023000699A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3982960T3 (fi) | Perinnöllisen angioödeeman hoitoja | |
| MXPA06012116A (es) | Uso de flibanserina en el tratamiento del trastornos premestruales y otros trastornos sexuales femeninos. | |
| CA2549801A1 (en) | Use of treprostinil to improve kidney functions | |
| EP1704860B1 (en) | Benzamidine derivatives for treatment and prevention of mucositis | |
| RU2012121185A (ru) | Фармацевтические композиции комбинаций ингибиторов дипептидилпептидазы-4 с пиоглитазоном | |
| MX2014011291A (es) | Uso de un derivado de pirazol en el tratamiento de exacerbaciones agudas de la enfermedad pulmonar obstructiva cronica. | |
| AU2017204833A1 (en) | Compositions and methods for treatment of chronic fatigue | |
| US20070093520A1 (en) | Method of treatment of diarrhea-predominant irritable bowel syndrome in a subject | |
| JPWO2020249977A5 (zh) | ||
| JPWO2020249979A5 (zh) | ||
| CA3107624C (en) | Composition for eradicating helicobacter pylori | |
| WO2013191724A1 (en) | Compositions and methods for treatment of neuropsychological deficits | |
| AU2011283462B2 (en) | Therapeutic agent or prophylactic agent for neuropathic pain | |
| WO2020042719A1 (zh) | 肌苷在防治抑郁症中的应用 | |
| US9867789B2 (en) | Non-steroidal anti-inflammatory drugs for cough | |
| CN115317478A (zh) | 沙库巴曲缬沙坦类物质在制备药物成瘾和复吸药物的应用 | |
| EP1519728B1 (en) | 4-(2-fluorophenyl)-6-methyl-2(1-piperazinyl)thieno(2,3-d) pyrimidine in the treatment of functional bowel disorder | |
| JP2003535897A (ja) | アンギオテンシンｉｉアンタゴニストの新規使用法 | |
| JP2012031141A (ja) | 骨髄異形性症候群を治療するための組成物および方法 | |
| US7470690B2 (en) | 4-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidine in the treatment of functional bowel disorder | |
| RU2545687C1 (ru) | Способ эрадикации хеликобактер пилори гастродуоденальной зоны | |
| US20060241136A1 (en) | Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist | |
| US20240122956A1 (en) | Application of Naringin Combined with Rapamycin in Preparation of Medications for Treating Hyperlipidemia | |
| AU2014213251B2 (en) | Prophylactic or therapeutic drug for constipation | |
| JP5440502B2 (ja) | 過敏性腸症候群の治療方法 |